MedPath

Study will be done on patients coming for elective lower abdominal surgeries and effects of four different doses of dexmedetomidine with hyperbaric ropivacaine in spinal anaesthesia will be compared

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/07/070283
Lead Sponsor
Simran Naval
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All ASA Grade 1 and 2, patients scheduled for elective lower abdominal surgery under subarachnoid block

Exclusion Criteria

Patients with hypertension, diabetes, spinal deformity, coagulation disorder, drug allergy, cardiovascular , respiratory or neurological disorders, pregnant patients, height less than 140cm, BMI more than 30kg per meter square, impaired liver and renal function tests, ASA Grade 3, 4, local skin infections

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To asses onset and duration of sensory blockade from the time of drug adminitration <br/ ><br>2. Maximum sensory level achieved and time taken for it <br/ ><br>3.Time taken for 2 segment sensory regression <br/ ><br>4. Onset and duration of motor blockade <br/ ><br>5. Total duration of post op analgesiaTimepoint: 1.To asses onset and duration of sensory blockade from the time of administration of drug <br/ ><br>2. Maximum sensory level achieved and time taken for it <br/ ><br>3.Time taken for 2 segment sensory regression <br/ ><br>4. Onset and duration of motor blockade <br/ ><br>5. Total duration of post op analgesia every hour till time of rescue analgesia. <br/ ><br>Every outcome assessed every 30 seconds till 5 minutes, every 1 minuthe till next 10 minutes every 5 minutes till end of surgery
Secondary Outcome Measures
NameTimeMethod
Changes in hemodynamic parameters and adverse effectsTimepoint: 24 hours after spinal anaesthsia
© Copyright 2025. All Rights Reserved by MedPath